Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. - Wikidata - awgldk - TriplyDB

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34656353

about

Laparoscopic versus open gastrectomy for gastric cancer Laparoscopic versus open gastrectomy for gastric cancer On the road to standardization of D2 lymph node dissection in a European population of patients with gastric cancer Gastric cancer: Current status of lymph node dissection Upgrading the definition of early gastric cancer: better staging means more appropriate treatment Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives Classic tumor markers in gastric cancer. Current standards and limitations Towards curative therapy in gastric cancer: Faraway, so close!Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine Cancer and liver cirrhosis: implications on prognosis and management Immunological battlefield in gastric cancer and role of immunotherapies Positioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinoma Resection of Large Metachronous Liver Metastasis with Gastric Origin: Case Report and Review of the Literature Does finding early recurrence improve outcomes, and at what cost?18F-FDG PET/CT role in staging of gastric carcinomas: comparison with conventional contrast enhancement computed tomography.HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Evolution in the surgical management of gastric cancer: is extended lymph node dissection back in vogue in the USA?HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development.Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma Towards personalized perioperative treatment for advanced gastric cancer.Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer.Diagnosis and evaluation of gastric cancer by positron emission tomography Surgical management of gastric cancer: the East vs. West perspective Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients.Redefining early gastric cancer.Tumor regression and survival after perioperative MAGIC-style chemotherapy in carcinoma of the stomach and gastroesophageal junction.Application of laparoscopy in the diagnosis and treatment of gastric cancer.Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study.Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study.Single skip metastasis in sentinel lymph node: In an early gastric cancer.Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer.Prognostic Value of Metastatic No.8p LNs in Patients with Gastric Cancer.Regional Arterial Infusion Chemotherapy improves the Pathological Response rate for advanced gastric cancer with Short-term Neoadjuvant Chemotherapy.The Effect of Helicobacter pylori on Gastric Cancer Treated with Adjuvant Chemotherapy After Curative Resection.Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.Five biopsy specimens from the proximal part of the tumor reliably determine HER2 protein expression status in gastric cancer Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer.

P2860

Q24185996-5DEAB8D9-EB9E-42E9-99C5-8670BDDD8E04 Q24188239-CB01ABDE-F969-47EB-ABB2-E46A587073FB Q26744183-9E685B89-F403-4689-9131-6CE0A24E143C Q26766091-E622FE85-AA18-491D-AD11-689606DC7B9D Q26771392-310CD3FB-5BE6-4DD8-A8F2-011000568443 Q26774283-376C6BA6-FF7B-4E24-A1C4-73D49E3D6A70 Q26777296-B43DD225-0511-4CE5-96FC-380505C41ECF Q26778029-1F7483EE-535A-46C6-B6D5-96463C91F794 Q26779725-F17DFADF-4E90-4EEE-9771-73B41B24EF90 Q26783309-81797CEE-5510-44A6-839F-8F297C622804 Q26798400-9DADF2C5-3804-4CC7-AE17-441C7CB5A183 Q26800355-D62B3BA3-7D6B-43CE-9482-BEEEEA94A66B Q28068579-DA379AB5-A86C-4048-8E77-E8CD51C1C0C6 Q28071836-605EDABB-E626-405C-9E5A-13740F9C81A1 Q28079750-8919F4DB-2FF0-4E76-877E-C701419C9D2D Q28079913-D963E982-9F80-4AAB-9417-8CEA8D8355DC Q30249096-67E748C1-4E2D-41DC-8C49-1213E2D67D52 Q30400422-03B2DCC1-88D7-4DE1-9CA7-178FE2AD16EA Q30837184-09405FF0-F696-41A2-ABD7-B22F5F7AC61E Q33912865-F188BA83-EB23-43B8-8E32-4275913A95E3 Q33917507-ACC41C37-D2FC-4520-83C2-00B41E420C71 Q34130176-EB686592-4285-4DB7-B7EE-0FCDFF0574F3 Q34137285-CC221A96-7678-4755-B709-F368B98E798A Q34255463-1BE41D00-FBC6-4865-888C-2FDD4F80561C Q34661633-5F489153-30C4-44CC-BAA7-5D2785992F55 Q34962070-EDE55436-70B9-480B-94B3-B077B935D648 Q35110064-B6F83E04-08BE-4297-9A0E-1A87216CE22F Q35591525-2194903C-F30A-48C8-88A9-DE20EB830E8B Q35633809-CDF88C71-67AB-4B59-A563-2BDFB7A29E8F Q35783616-251CC17C-820E-4D07-9642-62C19A0CF6E4 Q35925464-CF660EDE-CB5D-4068-9580-C054D5AC36FC Q35940367-A19D48A3-A4A3-42A3-8622-4B798D75A92F Q36037953-1642CA6F-F95C-4D8B-B75A-6777DBC17A23 Q36107240-B4F8062B-6A99-4377-BED8-B4FFC03CCF0A Q36328902-07E535EC-34D4-4180-ACF1-4EE048E6AD7A Q36333418-B0FBA081-00A4-45C2-9A4C-6FA2AEE3E46F Q36552720-013FC424-EC51-474F-8520-BB7A0F21C6E1 Q36639784-403F20A9-4159-412C-890C-C97B2B583B6D Q36778082-E64BD05C-416F-4D67-B055-67A01D35895C Q36860418-C7646075-A411-4774-A6FF-3448A41B851F

P2860

Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

http://www.wikidata.org/entity/Q34656353

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@ast

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@en

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@nl

type

label

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@ast

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@en

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@nl

prefLabel

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@ast

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@en

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@nl

P1433

Q34656353-68F8CFD8-7E6D-4D60-9B1A-C29289FFF3AC

P1476

Q34656353-E98567DB-66D6-4D9E-A128-C386B5EF6945

P2093

Q34656353-2B7F8233-38F6-4BEA-8165-68782D4DF58C

Q34656353-3398603C-E680-400A-87C6-5070CE8591BE

Q34656353-39AEC934-0E3C-4A28-943F-2E2BAF89E04C

Q34656353-3BB27048-39C1-40E7-9C2F-49E38C61D6FE

Q34656353-5368CD29-F3AE-41D9-A83E-BEEC6B91A779

Q34656353-6908E67E-6785-4BD8-85EC-BF02EE7DB62E

Q34656353-FB9697F2-24A5-4848-8B53-671BEC8F61E2

P2860

Q34656353-018A90D7-FDC4-4618-88A1-93DAEC55D3B3

Q34656353-041EB0F2-171F-4242-99CD-897EA7A9E8EC

Q34656353-04348CE0-A848-43EE-BB15-28151576F5E0

Q34656353-04FF70B3-0FC7-4FFF-8E0C-7E897A11DE64

Q34656353-0843FDB8-2E6F-4F08-8D5A-1B0C4F4172F0

Q34656353-0BBF1F3B-77E0-4BFB-995C-C2EAC4EA71E2

Q34656353-12EDF94A-90CD-453E-BFAC-138F717B0268

Q34656353-1560A0A9-0DD2-4B22-AE85-B5FAAB183EC2

Q34656353-241A6F6F-14BA-4ACA-8FB5-D81E920C3228

Q34656353-25DB6021-853C-4BE7-8503-67F3B1538CFC

P304

Q34656353-302802F8-527B-4ECE-B408-53092436C63C

P31

Q34656353-C2373096-92FC-4607-8416-51086449A397

P356

Q34656353-2382D6D2-AC57-4A5B-A64E-E0231D62AE6B

P478

Q34656353-220F4892-5C97-45D2-BFED-EA1023922E63

P50

Q34656353-52444CE4-F8E4-4DAF-8814-968AC2E9C527

Q34656353-5C87DA6C-AAAF-4EB9-AD01-42BACF248F14

P577

Q34656353-EEB47AB8-804A-4E2D-8465-2D960D9956B6

P698

Q34656353-76058B13-A672-4452-9939-7726C8D87E80

P356

P1433

Annals of Oncology

P1476

Gastric cancer: ESMO-ESSO-ESTR ...... osis, treatment and follow-up.

@en

P2093

A Cervantes

http://www.w3.org/2001/XMLSchema#string

European Society for Medical Oncology (ESMO)

http://www.w3.org/2001/XMLSchema#string

European Society of Radiotherapy and Oncology (ESTRO)

http://www.w3.org/2001/XMLSchema#string

European Society of Surgical Oncology (ESSO)

http://www.w3.org/2001/XMLSchema#string

M Verheij

http://www.w3.org/2001/XMLSchema#string

T Waddell

http://www.w3.org/2001/XMLSchema#string

W Allum

http://www.w3.org/2001/XMLSchema#string

P2860

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction.

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

Mucosectomy for gastric cancer: current status in Japan.

Guidelines for the management of oesophageal and gastric cancer.

P304

vi57-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDT344

http://www.w3.org/2001/XMLSchema#string

P478

24 Suppl 6

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24078663

http://www.w3.org/2001/XMLSchema#string